Skip to content

The Challenge of Diagnosing HIV Infection in LA PrEP Users

  • Dorrit Walsh

By Richard Jefferys Impressive results from two efficacy trials of a long-acting form of the integrase inhibitor cabotegravir (CAB LA) have boosted prospects for long-acting HIV pre-exposure prophylaxis (PrEP).1,2 In both cases, CAB LA proved superior to oral Truvada PrEP…

Read more

Delivering on the Promise of Long-Acting Technologies

  • Dorrit Walsh

By Susan Swindells* and Mark Harrington This issue of TAGline explores the exciting opportunities and challenges that come with the development of long-acting formulations for the prevention and treatment of infectious diseases. For many years to date, patients and providers…

Read more
cover image of November 2020 TAGline

TAGline November 2020

  • Dorrit Walsh

'The Struggle of a Lifetime' (Continued): The words of the late Honorable John Lewis ring powerfully true today. In the U.S., as we welcome a new President-elect and Vice President-elect, we must also defend democracy to ensure a complete, peaceful transition of power. We engage in the struggles generations before us have advanced, despite myriad challenges and emerging new threats such as COVID-19.

Read more

TAGline May 2020

  • Dorrit Walsh

Realizing the Right to Science: When we started to put together this issue of TAGline, we had no idea that COVID-19 was about to make its appearance and wreak havoc on every country of the world.

Read more
Back To Top